Hemostatic Therapy on Preventing Hematoma Enlargement in Acute Intracerebral Hemorrhage

Abstract

Abstract:

Past studies have evidenced the strong relationship between hematoma enlargement after intracerebral hemorrhage (ICH) and early neurological deterioration, indicating poor clinical outcome. Hematoma enlargement is a potentially important therapeutic target. However, hemostatic therapy to all ICH patients indiscriminately does not improve functional outcome, but increases the incidence of arterial thromboembolic adverse events (TAE). Contrast extravasation on CT angiography, namely “spot sign”, predicts hematoma expansion and poor prognosis in acute intracerebral hemorrhage with safety and efficacy. It plays a central role in prevention of early deterioration and improvement of functional outcome to rely on the “spot sign” for the selection of patients to receive early hemostatic therapy with safe and economical hemostatic agents. This study summarizes the related research situation and trend, so as to provide reference for clinical practice.

Key words: Intracerebral hemorrhage; Hematoma enlargement; Hemostatic therapy; Spot sign; Prognosis

摘要：

既往研究证实，脑出血后血肿扩大与早期神经功能恶化密切相关，往往预示着不良临床结局。血肿扩大是脑出血具有前景的治疗靶点。若不加筛选地对所有脑出血患者进行止血治疗，不但不能改善功能结局，反而可能增加动脉血栓栓塞不良事件风险。计算机断层扫描血管造影（computed tomography angiography，CTA）点样征是血肿扩大和不良预后安全有效的预测指标。应用点样征筛选血肿扩大高风险患者，并选用安全、经济的止血药物进行个体化止血治疗，对于遏制患者早期病情恶化及改善预后有重要意义。

关键词: 脑出血; 血肿扩大; 止血治疗; 点样征; 预后

CHEN Yao-Zhi, LIU Li-Ping. Hemostatic Therapy on Preventing Hematoma Enlargement in Acute Intracerebral Hemorrhage[J]. Chinese Journal of Stroke, 2016, 11(05): 408-413.

陈瑶枝，刘丽萍. 急性脑出血早期血肿扩大止血治疗研究进展[J]. 中国卒中杂志, 2016, 11(05): 408-413.

References

1 van Asch CJ，Luitse MJ，Rinkel GJ，et al. Incidence，

case fatality，and functional outcome of intracerebral

haemor rhage over time，according to age，sex，

and ethnic origin：a systematic review and metaanalysis[

J]. Lancet Neurol，2010，9：167-176.

2 Liu L，Wang D，Wong KS，et al. Stroke and stroke care

in China：huge burden，significant workload，and a

national priority[J]. Stroke，2011，42：3651-3654.

3 Wang W，Lu J，Wang Y，et al. Clinical characteristics，

management，and functional outcomes in Chinese

patients within the first year after intracerebral

hemorrhage：analysis from China National Stroke

Registry[J]. CNS Neurosci Ther，2012，18：773-780.

4 Dowlatshahi D，Demchuk AM，Flaherty ML，et

al. Defining hematoma expansion in intracerebral

hemorrhage：relationship with patient outcomes[J].

Neurology，2011，76：1238-1244.

5 Ka z u i S，Na r i tomi H，Yamamoto H，e t a l .

Enlargement of spontaneous intracerebral hemorrhage Incidence and time course[J]. Stroke，1996，27：1783-

1787.

6 Chang GY. Hematoma growth is a determinant

of mortality and poor outcome after intracerebral

hemorrhage[J]. Neurology，2006，66：1175-1181.

7 Delcourt C，Huang Y，Arima H，et al. Hematoma

growth and outcomes in intracerebral hemorrhage：the

INTERACT1 study[J]. Neurology，2012，79：314-319.

8 Brouwers HB，Greenberg SM. Hematoma expansion

following acute int racerebral hemor rhage[J ].

Cerebrovasc Dis，2013，35：195-201.

9 Brouwers HB，Chang Y，Falcone GJ，et al. Predicting

hematoma expansion after primary intracerebral

hemorrhage[J]. JAMA Neurol，2014，71：158-164.

10 Leira R，Davalos A，Silva Y，et al. Early neurologic

deterioration in intracerebral hemorrhage：predictors

and associated factors[J]. Neurology，2004，63：461-467.

11 Ohwaki K，Yano E，Nagashima H，et al. Blood

pressure management in acute int racerebr al

hemorrhage：relationship between elevated blood

pressure and hematoma enlargement[J]. Stroke，2004，

35：1364-1367.

12 Yang Q，Zhuang X，Peng F，et al. Relationship

of pla sma mat r ix met al loprot eina se -9 and

hematoma expansion in acute hypertensive cerebral

hemorrhage[J]. International Journal of Neuroscience，

2016，126：213-218.

13 Silva Y，Leira R，Tejada J，et al. Molecular signatures

of vascular injury are associated with early growth of

intracerebral hemorrhage[J]. Stroke，2005，36：86-91.

14 Behrouz R. Re-exploring tumor necrosis factor alpha

as a target for therapy in intracerebral hemorrhage[J].

Transl Stroke Res，2016，7：93-96.

15 Wada R，Aviv RI，Fox AJ，et al. CT angiography

"spot sign" predicts hematoma expansion in acute

intracerebral hemorrhage[J]. Stroke，2007，38：1257-

1262.

16 Kim J，Smith A，Hemphill JC 3rd，et al. Contrast

ext r ava sat ion on CT predi c ts mor t al i t y in

primary intracerebral hemorrhage[J]. AJNR Am J

Neuroradiol，2008，29：520-525.

17 Delgado Almandoz JE，Yoo AJ，Stone MJ，et

al. Systematic characterization of the computed

tomography angiography spot sign in pr imary

intracerebral hemorrhage identifies patients at highest

risk for hematoma expansion：the spot sign score[J].

Stroke，2009，40：2994-3000.

18 Delgado Almandoz JE，Yoo AJ，Stone MJ，et al. The

spot sign score in primary intracerebral hemorrhage

identifies patients at highest risk of in-hospital

mortality and poor outcome among survivors[J]. Stroke，2010，41：54-60.

19 Li N，Wang Y，Wang W，et al. Contrast extravasation

on computed tomography angiography predicts

clinical outcome in primary intracerebral hemorrhage：

a prospective study of 139 cases[J]. Stroke，2011，42：

3441-3446.

20 Demchuk AM，Dowlatshahi D，Rodriguez-Luna D，

et al. Prediction of haematoma growth and outcome

in patients with intracerebral haemorrhage using the

CT-angiography spot sign (PREDICT)：a prospective

observational study[J]. Lancet Neurol，2012，11：307-

314.

21 Holbrook A，Schulman PS，Witt DM，et al. Evidencebased

management of anticoagulant therapy[J]. Chest，

2012，141：e152S-e184S.

22 Brown JR，Birkmeyer NJ，O'Connor GT. Metaanalysis

comparing the effectiveness and adverse

outcomes of antif ibrinolytic agents in cardiac

surgery[J]. Circulation，2007，115：2801-2813.

23 Jalpa M，Saloni P，Jyotsna G. Antifibrinolytics in

liver surgery[J]. Indian J Anaesth，2010，54：489-495.

24 Baharoglu MI1，Germans MR，Rinkel GJ，et al.

Antifibrinolytic therapy for aneurysmal subarachnoid

haemorrhage[J]. Cochrane Database Syst Rev，2013，

30：CD001245.

25 Piriyawat P，Morgenstern LB，Yawn DH，et al.

Treatment of acute intracerebral hemorrhage with

epsilon-aminocaproic acid：a pilot study[J]. Neurocrit

Care，2004，1：47-51.

26 Sor imachi T，Fujii Y，Mor ita K，et al. Rapid

Administration of antifibrinolytics and strict blood

pressure control for intracerebral hemorrhage[J].

Neurosurgery，2005，57：837-844.

27 Sprigg N，Renton CJ，Dineen RA，et al. Tranexamic

acid for spontaneous intracerebral hemorrhage：a

randomized controlled pilot trial ( ISRCTN50867461)

[J]. J Stroke Cerebrovasc Dis，2014，23：1312-1318.

28 Mayer SA，Brun NC，Begtrup K，et al. Recombinant

act ivated factor Ⅶ for acute int racer ebr a l

hemorrhage[J]. N Engl J Med，2005，352：777-785.

29 Mayer SA，Brun NC，Begtrup K，et al. Efficacy and

safety of recombinant activated factor Ⅶ for acute

intracerebral hemorrhage[J]. N Engl J Med，2008，358：

2127-2137.

30 Mayer SA，Davis SB，Brun N，et al. Can a subset

of intracerebral hemorrhage patients benefit from

hemostatic therapy with recombinant activated factor

Ⅶ?[J]. Stroke，2009，40：833-840.

31 Yuan ZH，Jiang JK，Huang WD，et al. A metaanalysis

of the efficacy and safety of recombinant

activated factor Ⅶ for patients with acute intracerebral hemorrhage without hemophilia[J]. J Clin Neurosci，

2010，17：685-693.

32 Flaherty ML，Jauch EC. The Spot Sign for Predicting

and Treating ICH Growth Study (STOP-IT)[EB/

OL]. [2016-01-28]. http：//clinicaltrials. gov/show/

NCT00810888.

33 Gladstone DJ. "Spot Sign" Selection of Intracerebral

Hemor rhage to Guide Hemos t at ic The r apy

(SPOTLIGHT) [EB/OL]. [2016-01-28]. ht tp：//

clinicaltrials.gov/show/NCT01359202.

34 Meretoja A，Churilov L，Campbell BC，et al. The

Spot sign and Tranexamic acid On Preventing ICH

growth -AUStralasia Trial (STOP-AUST)：Protocol

of a phase II randomized，placebo-cont rolled，

double-blind，multicenter trial[J]. Int J Stroke，2014，

9：519-524.

35 Davis SM，Donnan GM. Tranexamic acid for

int racerebral haemor rhage TICH-2[EB/OL].

[2016-01-28]. http://www.controlled-trials.com/

ISRCTN93732214/.

[1]	WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033.
[2]	LI Yangyang, FANG Jian, WANG Xiaoxue. Effects of Honokiol on Neurological Injury and Cognitive Function in Mice with Intracerebral Hemorrhage by Regulating BDNF-TrkB-CREB Signaling Pathway [J]. Chinese Journal of Stroke, 2024, 19(9): 1048-1057.
[3]	ZHOU Hongyu, LI Zixiao, WANG Yongjun. Research Progress on Radiomics-Based Brain Age Prediction and Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1066-1076.
[4]	ZHAO Yan, YAO Jingxin, PENG Yuming. A Report of Simultaneous Complications of Ischemic Stroke and Intracerebral Hemorrhage in Geriatric Patients Undergoing Craniotomy for Tumor Resections during the Perioperative Period [J]. Chinese Journal of Stroke, 2024, 19(7): 797-802.
[5]	YU Dandan, QIN Haiqiang, WANG Anxin, ZHANG Xiaoli, ZUO Yingting, ZHANG Yaqing, YANG Bo, WEI Na, ZHANG Jing. Effect of Body Mass Index on Short-Term Prognosis of Stroke Patients with Different Severity [J]. Chinese Journal of Stroke, 2024, 19(7): 809-814.
[6]	LI Zhiming, WANG Zijie, LI Qi. Interpretation of the American Stroke Association Code ICH Expert Consensus Statement [J]. Chinese Journal of Stroke, 2024, 19(6): 714-724.
[7]	LI Chenhong, JIANG Chenli, WANG Jinhui, HUANG Sheng. Analysis of Influencing Factors and Construction of Prediction Models for Pulmonary Infection after Minimally Invasive Intracranial Hematoma Removal in Patients with Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(5): 532-538.
[8]	DING Zeyu, JI Zeqiang, WU Jianwei, KANG Kaijiang, ZHAO Xingquan. Risk Factors of Early Neurological Deterioration of Patients after Minimally Invasive Surgery in Supratentorial Hypertensive Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(5): 545-551.
[9]	Ciyang, HU Yaxiong, WANG Qiqi, LIAN Yuqing, CHEN Yuxiu, ZHOU Lixin, ZHAO Yuhua. Clinical and Prognostic Characteristics of Post-Stroke Epilepsy at High Altitude [J]. Chinese Journal of Stroke, 2024, 19(4): 423-430.
[10]	ZHANG Qing, WANG Xu, ZHANG Qing. A Case Report of “Heart” Shaped Primary Medullary Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(2): 197-201.
[11]	WANG Jiwei, LI Hui, LIU Jianfeng, XU Lifeng, BI Hongling, XIE Xiongwei, TIAN Yangyang. Study on the Value of YKL-40 and Caspase-1 Levels and ASPECTS in Predicting the Prognosis of Patients with Anterior Circulation Massive Cerebral Infarction after Interventional Thrombectomy [J]. Chinese Journal of Stroke, 2024, 19(10): 1155-1161.
[12]	CHEN Xubin, XIAO Weiting, YUE Xifeng, HE Nengqing, ZENG Xiaohui. Relationship between Serum MicroRNA-874-3p, MicroRNA-181a-5p, Wnt/β-catenin Signaling Pathway and Neurological Function Prognosis in Patients with Acute Ischemic Stroke after Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(10): 1162-1169.
[13]	LI Dayu, GUO Shaolei, ZHANG Bo, HUANG Zhipeng, YE Weiwei, YAO Liang. Effects of Penehyclidine Hydrochloride on the Blood-Brain Barrier and ROCK2, CLDN5, and AQP-4 Expression of Brain Tissue in Rats with Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(10): 1180-1187.
[14]	JU Jiajun, WANG Xinxin, HANG Lihua. Research Progress on the Correlation between Neuroinflammation and Brain Iron Metabolism after Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(10): 1205-1214.
[15]	The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases. Medical Quality Control Indicators for Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(1): 44-49.